Assessing Treatment Efficacy in Infants with RSV Bronchiolitis
Author Information
Author(s): Beck Raphael, Elias Nael, Shoval Shay, Tov Naveh, Talmon Gil, Godfrey Simon, Bentur Lea
Primary Institution: Rambam Medical Center, Technion, Haifa, Israel
Hypothesis
Automated quantification of wheezing and crackles is equal or superior to the clinical score in assessing the infants' response to treatment.
Conclusion
Computerized lung sound analysis is feasible in young infants with RSV bronchiolitis and provides a non-invasive, quantitative measure of wheezing and crackles.
Supporting Evidence
- The study included 27 infants with RSV bronchiolitis.
- No significant change in wheezing and crackles was found between treatment groups.
- The study demonstrated the feasibility of computerized lung sound analysis in infants.
Takeaway
The study looked at how well two treatments work for babies with a lung infection, but found that neither treatment worked better than the other.
Methodology
Infants were randomized to receive either nebulized epinephrine or albuterol, and lung sounds were analyzed before and after treatment.
Potential Biases
Potential bias in clinical scoring as it was observer-dependent.
Limitations
The study was a pilot and not powered to detect clinical response differences.
Participant Demographics
Infants aged 2-12 months with RSV bronchiolitis; 12 received epinephrine and 15 received albuterol.
Statistical Information
P-Value
p<0.04 for respiratory rate at 10 minutes, p<0.02 for heart rate at 30 minutes.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website